Induction of Immune Tolerance after Haploidentical Stem Cell Transplantation Following Solid Organ Transplantation in Patients with Sickle Cell Disease

Key Points

• Immune tolerance is successfully induced in patients with sickle cell disease undergoing haploidentical stem cell transplantation.
• Key metric shows a reduced incidence of graft-versus-host disease after transplantation in these patients.
• This observational analysis focuses on patients who received solid organ transplantation prior to stem cell therapy.
• Success in inducing tolerance may improve overall outcomes; further studies are needed to validate these findings.